Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
2.32M
Number of holders
13
Total 13F shares, excl. options
1.56M
Shares change
-59.8K
Total reported value, excl. options
$16.9M
Value change
-$618K
Number of buys
4
Number of sells
-6
Price
$10.87

Significant Holders of Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) as of Q3 2024

15 filings reported holding BLAC - Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share as of Q3 2024.
Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.56M shares of 2.32M outstanding shares and own 67.09% of the company stock.
Largest 10 shareholders include WOLVERINE ASSET MANAGEMENT LLC (267K shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (245K shares), COWEN AND COMPANY, LLC (186K shares), BERKLEY W R CORP (174K shares), Walleye Capital LLC (168K shares), CLEAR STREET LLC (131K shares), AQR Arbitrage LLC (125K shares), Walleye Trading LLC (94.6K shares), Warberg Asset Management LLC (80.2K shares), and Quarry LP (65K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.